2022
DOI: 10.1016/bs.seda.2022.08.011
|View full text |Cite
|
Sign up to set email alerts
|

Drugs used in the treatment of tuberculosis and leprosy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 87 publications
0
1
0
Order By: Relevance
“…It is estimated that approximately 30% of the global population are carriers of this bacterium, and every year, the World Health Organization reports numerous diseases and deaths caused by its infection [ 2 ]. The tuberculosis treatment process is very demanding for patients, not only because of the extended duration of therapy but also because of the side effects that occur after taking tuberculosis drugs, such as nausea, hearing loss, or hepatotoxicity [ 3 , 4 ]. Immunocompromised patients, including those using immunosuppressive drugs or who are HIV-positive, are at higher risk of tuberculosis [ 5 , 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…It is estimated that approximately 30% of the global population are carriers of this bacterium, and every year, the World Health Organization reports numerous diseases and deaths caused by its infection [ 2 ]. The tuberculosis treatment process is very demanding for patients, not only because of the extended duration of therapy but also because of the side effects that occur after taking tuberculosis drugs, such as nausea, hearing loss, or hepatotoxicity [ 3 , 4 ]. Immunocompromised patients, including those using immunosuppressive drugs or who are HIV-positive, are at higher risk of tuberculosis [ 5 , 6 ].…”
Section: Introductionmentioning
confidence: 99%